Nurix Therapeutics
NRIX
#4606
Rank
โ‚ฌ1.77 B
Marketcap
17,49ย โ‚ฌ
Share price
-5.29%
Change (1 day)
-10.57%
Change (1 year)

Revenue for Nurix Therapeutics (NRIX)

Revenue in 2025 (TTM): โ‚ฌ75.9 Million

According to Nurix Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ71.97 Million. In 2024 the company made a revenue of โ‚ฌ52.41 Million a decrease over the revenue in the year 2023 that were of โ‚ฌ69.64 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Nurix Therapeutics from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ75.9 M44.8%
2024 โ‚ฌ52.41 M-24.73%
2023 โ‚ฌ69.64 M93.4%
2022 โ‚ฌ36.01 M37.08%
2021 โ‚ฌ26.26 M81.32%
2020 โ‚ฌ14.48 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA